- Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
- Hydroxychloroquine works in high-risk patients, and saying otherwise is dangerous
- WHO “Solidarity” and UK “Recovery” Clinical Trials of Hydroxychloroquine Using Potentially Fatal Doses
- Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection
- Countries which Primarily Use Antimalarial Drugs As COVID-19 Treatment See Slower Dynamic of Daily Deaths
- Evidence for Health Decision Making — Beyond Randomized, Controlled Trials
